Lv3
300 积分 2022-08-01 加入
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
10天前
已完结
VEGF-targeted therapy: mechanisms of anti-tumour activity
1个月前
已完结
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
2个月前
已完结
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
2个月前
已完结
Reverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review
2个月前
已完结
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
2个月前
已完结
Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells
2个月前
已完结
Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers
7个月前
已完结
Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
7个月前
已完结
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
7个月前
已完结
皖公网安备34019202002308
